Real World Data – Otawa Health

Market size and opportunity

Sources: IQVIA Institute 2022; DataSUS 2022; Global Cancer Observatory; Citeline; IQVIA Midas, IMF.

Population	6th largest	214M
Pharma market	8th largest	USD 15B
GDP	10th largest	USD 1,8T
New cancer cases per year	6th largest	600,000
Number of oncologists	3th largest	8,500
Participation in clinical studies	19th
Data for global cancer studies	2%

Despite its huge population, the amount of new cancer cases per year, and having the 3rd largest number of oncologists in the world, Brazil only ranks 19th in participation in clinical studies and contributes with only 2% of all data used in global oncology studies.

The two main reasons for such poor participation:
• Lack of specialized software to collect cancer data.
• Lack of high quality structured data sets for oncology.

Global Real-World Data necessity

Global expenditures in oncology will keep growing between 9% to 21% per year until 2026.

Across all therapy areas, oncology accounts for 47% of the next-generation biotherapeutic pipeline, highlighting a significant amount of research and promise to improve care for cancer patients.

The use of real-world evidence is increasingly part of regulatory submissions and already included in the approval decisions from the FDA.

Achieving racial and ethnic representation in clinical trials remains a challenge. With a highly heterogeneous population, data collected in Brazil has the potential to contribute relevant information towards clinical studies.

A DIGITAL ONCOLOGY platform made of a specialized oncology-EHR/CDS solution created BY and FOR cancer care professionals.

OTAWA Health contributes to better management of cancer centers enabling a comprehensive and coordinated care while collecting structured oncology Real-World Data for Real-World Evidence studies to improve outcomes for patients with cancer.

We are a Brazilian health tech company based in São Paulo. Contact us here.

Follow us on LinkedIn